Cardiogenic Shock in Cardiac Surgery Patients: Why Continuous Physiologic Data Matters

Cardiac surgery patients don’t come from a single mold. A valve repair patient, a transplant recipient, a CABG patient, and a patient recovering from aortic surgery each carry a different hemodynamic profile and a different trajectory through the ICU. What they share is vulnerability, particularly to one of the most dangerous complications in post-surgical critical care: cardiogenic shock.

Managing cardiogenic shock after cardiac surgery isn’t a single-moment decision. It’s a process that evolves through the CICU and requires constant reassessment as patients move toward stabilization, de-escalation, and recovery.

What Makes Cardiogenic Shock So Dangerous in Cardiac Surgery Patients?

Baseline cardiac injury is already present. 

These patients have undergone significant myocardial stress before arriving in theICU. Cardiopulmonary bypass, ischemia-reperfusion injury, and the underlying disease that prompted surgery all compress the heart’s reserve. There’s less margin.

Staging is hard to track without continuous data.

The SCAI shock classification framework – stages A through E – provides a structured approach to assessing shock severity, but applying it meaningfully requires continuous, aggregated physiologic data, not point-in-time snapshots. A patient moving from Stage B to Stage C doesn’t announce it with a single flag. It’s a gradual trend across multiple parameters.

The data needed to act is often fragmented. 

The information required to make consistent, well-timed care decisions — across shifts and patient types – is typically scattered across bedside devices, EMR entries, and manual assessments. That fragmentation creates gaps exactly where continuity matters most.

What Continuous Physiologic Data and Clinical Intelligence  Changes

When care teams have aggregated, real-time physiologic data organized around institution-configured clinical pathways, clinical assessment becomes more structured and consistent.

For cardiogenic shock patients specifically, the Etiometry Platform supports automated application of hospital-defined SCAI shock classification and tracking criteria to flag patients for clinical review. When predefined criteria are met,  Etiometry supports timely care team assessment, provides objective clinical data for review, and augments the clinician workflow.

FDA Clearance

In April 2026, Etiometry received FDA clearance (K254066) for the Cardiogenic Shock Tool, the first solution of its kind designed to automate hospital-specific cardiogenic shock classification and tracking directly from physiologic monitoring data. The tool applies Society for Cardiovascular Angiography & Interventions (SCAI) guidelines and staging criteria, configured to each hospital’s protocols, to support standardized, hospital-wide surveillance of shock progression. By integrating high-fidelity physiologic data with EHR, lab, and device inputs, the platform gives cardiac care teams a continuous, consolidated view of hemodynamic and organ function status, supporting clinician review of shock progression, therapeutic response, and care coordination across the OR, ICU, step-down units, and telemetry.

Built for the Complexity of Cardiac Critical Care

The Etiometry Platform Cardiogenic Shock Tool:

• Enables earlier and more accurate staging of cardiogenic shock than traditional EHR-based methods by leveraging continuous, high-frequency  physiologic data rather than intermittent documentation.  
• Provides a real-time, objective shock severity classification that is independent of, and complementary to, clinician-entered EHR data, which frequently lags behind evolving patient physiology.
• Overcomes key EHR limitations, including delayed recognition, subjective interpretation, and incomplete documentation, by applying standardized, data-driven shock criteria at the bedside.
• Quantifies cumulative hypotension and hypoperfusion burden using continuously captured signals.

• Reveals substantial under-recognition and under-coding of cardiogenic shock in the EHR, identifying patients with objective physiologic evidence of shock who lack corresponding documentation.

These capabilities support Etiometry as an enabling infrastructure that augments the EHR, transforming raw physiologic data into actionable, real-time insight for comprehensive cardiogenic shock management.

*In observational studies at select sites; results vary by site and population. Not designed to prove causality. The Etiometry Platform is intended to aid decision-making, not to improve outcomes independently.